Skip to main content
construction release_alert
Scholars@Duke will be down for maintenance for approximately one hour starting Tuesday, 11/11 @1pm ET
cancel
Journal cover image

TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response.

Publication ,  Journal Article
Zeng, Z; Wong, CJ; Yang, L; Ouardaoui, N; Li, D; Zhang, W; Gu, S; Zhang, Y; Liu, Y; Wang, X; Fu, J; Zhou, L; Zhang, B; Kim, S; Yates, KB ...
Published in: Nucleic Acids Res
January 7, 2022

Syngeneic mouse models are tumors derived from murine cancer cells engrafted on genetically identical mouse strains. They are widely used tools for studying tumor immunity and immunotherapy response in the context of a fully functional murine immune system. Large volumes of syngeneic mouse tumor expression profiles under different immunotherapy treatments have been generated, although a lack of systematic collection and analysis makes data reuse challenging. We present Tumor Immune Syngeneic MOuse (TISMO), a database with an extensive collection of syngeneic mouse model profiles with interactive visualization features. TISMO contains 605 in vitro RNA-seq samples from 49 syngeneic cancer cell lines across 23 cancer types, of which 195 underwent cytokine treatment. TISMO also includes 1518 in vivo RNA-seq samples from 68 syngeneic mouse tumor models across 19 cancer types, of which 832 were from immune checkpoint blockade (ICB) studies. We manually annotated the sample metadata, such as cell line, mouse strain, transplantation site, treatment, and response status, and uniformly processed and quality-controlled the RNA-seq data. Besides data download, TISMO provides interactive web interfaces to investigate whether specific gene expression, pathway enrichment, or immune infiltration level is associated with differential immunotherapy response. TISMO is available at http://tismo.cistrome.org.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Nucleic Acids Res

DOI

EISSN

1362-4962

Publication Date

January 7, 2022

Volume

50

Issue

D1

Start / End Page

D1391 / D1397

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Software
  • Neoplasms
  • Mice
  • Immunotherapy
  • Humans
  • Disease Models, Animal
  • Developmental Biology
  • Databases, Genetic
  • Biomarkers, Pharmacological
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Zeng, Z., Wong, C. J., Yang, L., Ouardaoui, N., Li, D., Zhang, W., … Liu, X. S. (2022). TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res, 50(D1), D1391–D1397. https://doi.org/10.1093/nar/gkab804
Zeng, Zexian, Cheryl J. Wong, Lin Yang, Nofal Ouardaoui, Dian Li, Wubing Zhang, Shengqing Gu, et al. “TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response.Nucleic Acids Res 50, no. D1 (January 7, 2022): D1391–97. https://doi.org/10.1093/nar/gkab804.
Zeng Z, Wong CJ, Yang L, Ouardaoui N, Li D, Zhang W, et al. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 2022 Jan 7;50(D1):D1391–7.
Zeng, Zexian, et al. “TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response.Nucleic Acids Res, vol. 50, no. D1, Jan. 2022, pp. D1391–97. Pubmed, doi:10.1093/nar/gkab804.
Zeng Z, Wong CJ, Yang L, Ouardaoui N, Li D, Zhang W, Gu S, Zhang Y, Liu Y, Wang X, Fu J, Zhou L, Zhang B, Kim S, Yates KB, Brown M, Freeman GJ, Uppaluri R, Manguso R, Liu XS. TISMO: syngeneic mouse tumor database to model tumor immunity and immunotherapy response. Nucleic Acids Res. 2022 Jan 7;50(D1):D1391–D1397.
Journal cover image

Published In

Nucleic Acids Res

DOI

EISSN

1362-4962

Publication Date

January 7, 2022

Volume

50

Issue

D1

Start / End Page

D1391 / D1397

Location

England

Related Subject Headings

  • Tumor Microenvironment
  • Software
  • Neoplasms
  • Mice
  • Immunotherapy
  • Humans
  • Disease Models, Animal
  • Developmental Biology
  • Databases, Genetic
  • Biomarkers, Pharmacological